Diagnostic Performance of Platelet-to-Lymphocyte Ratio and CA19-9 Added to EUS-FNA for Solid Pancreatic Lesions: A Single-Center Retrospective Study
Shasha Liu, Chen Hu, Yujing Fan, Lina Liu, Ying Hu · 2026
Read Diagnostic Performance of Platelet-to-Lymphocyte Ratio and CA19-9 Added to EUS-FNA for Solid Pancreatic Lesions: A Single-Center Retrospective Study by Shasha Liu, Chen Hu, Yujing Fan, Lina Liu, Ying Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13525798.txt.
Description
Two cheap blood values may sharpen the diagnosis of solid growths in the pancreas, and a 2026 study by Shasha Liu and co-authors tests that idea. The standard test threads an ultrasound scope to the growth and draws cells with a fine needle, and the team asked whether adding the two values helps.
The study reviewed 127 patients at one center who had the needle test between 2020 and 2023, with final diagnoses set by an independent standard. Eighty growths proved malignant. The needle test alone was right in 91.3 percent of cases, with strong scores for both finding and ruling out cancer. The added values were a platelet-to-lymphocyte ratio and the tumor marker CA19-9, whose levels ran higher in cancer cases.
Catalog record
| CREATOR | Shasha Liu, Chen Hu, Yujing Fan, Lina Liu, Ying Hu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |